Matches in Wikidata for { <http://www.wikidata.org/entity/Q84553767> ?p ?o ?g. }
- Q84553767 description "2011 nî lūn-bûn" @default.
- Q84553767 description "2011年の論文" @default.
- Q84553767 description "2011年学术文章" @default.
- Q84553767 description "2011年学术文章" @default.
- Q84553767 description "2011年学术文章" @default.
- Q84553767 description "2011年学术文章" @default.
- Q84553767 description "2011年学术文章" @default.
- Q84553767 description "2011年学术文章" @default.
- Q84553767 description "2011年學術文章" @default.
- Q84553767 description "2011年學術文章" @default.
- Q84553767 description "2011年學術文章" @default.
- Q84553767 description "2011年學術文章" @default.
- Q84553767 description "2011年學術文章" @default.
- Q84553767 description "2011년 논문" @default.
- Q84553767 description "article científic" @default.
- Q84553767 description "article scientific" @default.
- Q84553767 description "article scientifique" @default.
- Q84553767 description "articol științific" @default.
- Q84553767 description "articolo scientifico" @default.
- Q84553767 description "artigo científico" @default.
- Q84553767 description "artigo científico" @default.
- Q84553767 description "artigo científico" @default.
- Q84553767 description "artikel ilmiah" @default.
- Q84553767 description "artikull shkencor" @default.
- Q84553767 description "artikulong pang-agham" @default.
- Q84553767 description "artykuł naukowy" @default.
- Q84553767 description "artículo científico publicado en 2011" @default.
- Q84553767 description "artículu científicu" @default.
- Q84553767 description "bilimsel makale" @default.
- Q84553767 description "bài báo khoa học" @default.
- Q84553767 description "naučni članak" @default.
- Q84553767 description "scienca artikolo" @default.
- Q84553767 description "scientific article published on 13 July 2011" @default.
- Q84553767 description "scientific article published on 13 July 2011" @default.
- Q84553767 description "scientific article published on 13 July 2011" @default.
- Q84553767 description "teaduslik artikkel" @default.
- Q84553767 description "tieteellinen artikkeli" @default.
- Q84553767 description "tudományos cikk" @default.
- Q84553767 description "vedecký článok" @default.
- Q84553767 description "vetenskaplig artikel" @default.
- Q84553767 description "videnskabelig artikel udgivet 13. juli 2011" @default.
- Q84553767 description "vitenskapelig artikkel" @default.
- Q84553767 description "vitskapeleg artikkel" @default.
- Q84553767 description "vědecký článek" @default.
- Q84553767 description "wetenschappelijk artikel" @default.
- Q84553767 description "wissenschaftlicher Artikel" @default.
- Q84553767 description "επιστημονικό άρθρο" @default.
- Q84553767 description "мақолаи илмӣ" @default.
- Q84553767 description "наукова стаття, опублікована в липні 2011" @default.
- Q84553767 description "научна статия" @default.
- Q84553767 description "научная статья" @default.
- Q84553767 description "научни чланак" @default.
- Q84553767 description "научни чланак" @default.
- Q84553767 description "מאמר מדעי" @default.
- Q84553767 description "مقالة علمية نشرت في 13 يوليو 2011" @default.
- Q84553767 description "১৩ জুলাই ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q84553767 description "บทความทางวิทยาศาสตร์" @default.
- Q84553767 description "სამეცნიერო სტატია" @default.
- Q84553767 name "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 name "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 type Item @default.
- Q84553767 label "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 label "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 prefLabel "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 prefLabel "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 P1433 Q84553767-869CA1D8-1ABE-471A-B300-63FC2EB392D0 @default.
- Q84553767 P1476 Q84553767-998D1FDA-685E-4547-9D18-7CC78273F715 @default.
- Q84553767 P2093 Q84553767-078B0B5D-AD98-420D-BE93-68538C722E6F @default.
- Q84553767 P2093 Q84553767-62058351-6DCE-40A2-B63F-6D389372C734 @default.
- Q84553767 P2093 Q84553767-7CE5C85D-85EB-46BD-A5BE-4CC732747C46 @default.
- Q84553767 P2093 Q84553767-8AE3FBE2-E935-46CC-BEE5-B4FA10ECE665 @default.
- Q84553767 P2093 Q84553767-9DECA5AE-D8B8-4375-A748-9620AB16BBE8 @default.
- Q84553767 P2093 Q84553767-9F4B494C-8256-4ADF-9FF7-B80F537379A5 @default.
- Q84553767 P2093 Q84553767-B3B7665E-80B0-4A09-8326-298E6C43410D @default.
- Q84553767 P2093 Q84553767-B51DEEE0-C242-4648-826C-86F7C0B4948C @default.
- Q84553767 P2093 Q84553767-D2673B3E-D0F0-4185-862C-0344AB167631 @default.
- Q84553767 P2093 Q84553767-EF6CED9F-FC8A-4C85-8070-0AC848CE8148 @default.
- Q84553767 P2093 Q84553767-F97F4D1C-7D2F-4FC6-8AC2-1482E6ABD6C1 @default.
- Q84553767 P304 Q84553767-4EEE517D-F42C-44CA-974A-5EC506124B09 @default.
- Q84553767 P31 Q84553767-D6F26E0F-ECC6-4239-A463-478C0FC9B7DC @default.
- Q84553767 P356 Q84553767-00C5F854-23AE-4AA7-8C10-CB6D09F115DA @default.
- Q84553767 P433 Q84553767-B0A306AE-EEFE-48A9-A8DE-39EE1DB320FA @default.
- Q84553767 P478 Q84553767-D0DCBB85-40C0-49A2-BDE5-12CA760450C6 @default.
- Q84553767 P50 Q84553767-1EFFC7B8-8BE8-4E4E-9AD2-79335575B8B0 @default.
- Q84553767 P50 Q84553767-D2144D48-44F5-4CE6-B24E-51E9087C7B47 @default.
- Q84553767 P577 Q84553767-D9E5E64F-793F-4A29-95D0-00D252A0F081 @default.
- Q84553767 P698 Q84553767-07F27A4D-2BD6-4508-B003-786E72A51D17 @default.
- Q84553767 P356 1078-0432.CCR-11-0353 @default.
- Q84553767 P698 21753156 @default.
- Q84553767 P1433 Q332253 @default.
- Q84553767 P1476 "Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors" @default.
- Q84553767 P2093 "Annemarie Nol" @default.
- Q84553767 P2093 "Christopher A Slapak" @default.
- Q84553767 P2093 "Emile E Voest" @default.
- Q84553767 P2093 "Ignacio Garcia-Ribas" @default.
- Q84553767 P2093 "Karim A Benhadji" @default.
- Q84553767 P2093 "Marlies H G Langenberg" @default.
- Q84553767 P2093 "Petronella O Witteveen" @default.
- Q84553767 P2093 "Robert S Jansen" @default.
- Q84553767 P2093 "Roelien H Kronemeijer" @default.